ALNY

Pre-Market

Alnylam Pharmaceuticals Inc

$472.61

$0.81 (-0.17%)

Kamis, 04 Desember 2025 09:02 WIB

$473.42

$8.51 (1.83%)

Rabu, 03 Desember 2025 20:59 WIB

61.42 B

Market Cap

Performa Harga

Harga kembali 1 minggu6.14%

Harga kembali 1 Bulan11.64%

Harga kembali 3 Bulan4.24%

Harga kembali 6 Bulan54.85%

Harga Tertinggi (52 Minggu)495.39

Harga Terendah (52 Minggu)205.81

Latar Belakang Perusahaan

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts.

Summary

Valuation Information

Current PE Ratio (TTM)1434.6

Forward PE Ratio51.28

Current Price to Book Value266.71

Current Price to Sales19.2

EV to Revenue18.27

EV to EBITDA314.18

PEG Ratio-

Per Share

Current EPS (Annualized)0.33

Diluted EPS (TTM)0.33

Revenue Per Share24.65

Current Book Value Per Share1.77

Dividend

Dividend Per Share-

Dividend Yield-

Ex Dividend Date-

Dividend Payment Date-

Income Statement

EBITDA321021000

Profit Margin0.0136

Operating Margin0.295

Feed

Berita

Broker Summary

Technical

Finansial

Laporan

Profil

Loading feeds...